Oramed Pharmaceuticals Inc (ORMP)
2.29
-0.08
(-3.38%)
USD |
NASDAQ |
Apr 25, 16:00
2.29
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Cash and Short Term Investments (Quarterly): 162.05M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 162.05M |
September 30, 2023 | 175.04M |
June 30, 2023 | 150.20M |
March 31, 2023 | 153.73M |
December 31, 2022 | 155.72M |
September 30, 2022 | 159.55M |
June 30, 2022 | 133.91M |
March 31, 2022 | 141.61M |
November 30, 2021 | 150.54M |
August 31, 2021 | 94.14M |
May 31, 2021 | 69.64M |
February 28, 2021 | 56.79M |
November 30, 2020 | 34.35M |
August 31, 2020 | 39.90M |
May 31, 2020 | 40.83M |
February 29, 2020 | 28.93M |
November 30, 2019 | 30.13M |
August 31, 2019 | 32.28M |
May 31, 2019 | 26.19M |
February 28, 2019 | 28.65M |
November 30, 2018 | 28.92M |
August 31, 2018 | 30.46M |
May 31, 2018 | 23.37M |
February 28, 2018 | 20.90M |
November 30, 2017 | 18.97M |
Date | Value |
---|---|
August 31, 2017 | 20.12M |
May 31, 2017 | 26.20M |
February 28, 2017 | 29.61M |
November 30, 2016 | 30.05M |
August 31, 2016 | 31.02M |
May 31, 2016 | 24.70M |
February 29, 2016 | 25.60M |
November 30, 2015 | 15.06M |
August 31, 2015 | 17.23M |
May 31, 2015 | 17.15M |
February 28, 2015 | 18.15M |
November 30, 2014 | 24.37M |
August 31, 2014 | 21.29M |
May 31, 2014 | 15.54M |
February 28, 2014 | 23.35M |
November 30, 2013 | 7.792M |
August 31, 2013 | 8.475M |
May 31, 2013 | 4.232M |
February 28, 2013 | 5.344M |
November 30, 2012 | 6.596M |
August 31, 2012 | 5.085M |
May 31, 2012 | 1.800M |
February 29, 2012 | 3.004M |
November 30, 2011 | 3.681M |
August 31, 2011 | 1.898M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
26.19M
Minimum
May 2019
175.04M
Maximum
Sep 2023
96.61M
Average
94.14M
Median
Aug 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Inogen Inc | 128.47M |
Petros Pharmaceuticals Inc | 13.34M |
DIH Holding US Inc | -- |
NovaBay Pharmaceuticals Inc | 3.13M |
Palatin Technologies Inc | 9.485M |